IMR Press / RCM / Special Issues / 1632968758046

Highlighting Excellence in Cardiovascular Research in Canada

Submission deadline: 31 December 2022
Special Issue Editors
Morris Karmazyn, MD
Professor of Physiology and Pharmacology (retired), University of Western Ontario, London, Canada and former Canada Research Chair in Experimental Cardiology (2004-2016)
Interests: Cardiac hypertrophy; Heart failure; Cardiac myocytes; Na-H exchange; Leptin; Traditional Chinese medicines
Special Issue Information

Dear Colleagues,

 

We are pleased to announce the upcoming publication of a Special Issue of Reviews in Cardiovascular Medicine dedicated to highlighting excellence in cardiovascular research in Canada.  Canadian researchers have an outstanding international reputation in many areas of cardiovascular research and have made important contributions to advancing our understanding and treatment of cardiovascular disorders.  The goal of this Special Issue is to highlight contributions made to the field in Canadian laboratories or by Canadian investigators.  Thus, the criteria for consideration for inclusion in the Special Issue is that the corresponding author should be a Canadian investigator or that the research was carried out primarily in a Canadian laboratory.  Contributions may be in the form of either a Review or an Original Research article.   

Topics to be covered include, but are not restricted to, the following: 

Molecular and cellular mechanisms underlying myocardial remodelling and heart failure
Protection of the ischemic and reperfused myocardium
Vascular health and hypertension
Role of obesity and adipokines in cardiovascular disease
Diabetes and cardiovascular complications 
Treatment of cardiovascular disease with natural products
Understanding cardiac arrhythmias
Cardiovascular pharmacology

I invite you to submit your contribution to this Special Issue of Reviews in Cardiovascular Medicine.  Deadline for submission is December 31, 2022.

Prof. Dr. Morris Karmazyn

Guest Editor

Keywords
Molecular
Cellular mechanisms
Myocardial remodelling
Heart failure
Protection
Ischemic and reperfused myocardium
Vascular health and hypertension
Obesity
Adipokines
Cardiovascular disease
Diabetes
Cardiovascular complications
Treatment
Natural products
Cardiac arrhythmias
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://jour.ipublishment.com/imr/access/login by registering and logging in to this website. Once you are registered, click here to start your submission Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted papers should be well formatted and use good English.

Published Paper (1 Paper)
Open Access Review
Bacteria and the growing threat of multidrug resistance for invasive cardiac interventions
Grant N. Pierce, Craig Resch, Muntahi Mourin, Pavel Dibrov, ... Amir Ravandi
Rev. Cardiovasc. Med. 2022, 23(1), 1; https://doi.org/10.31083/j.rcm2301015
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
4
Download
110
Views
Back to top